According to Taisho Pharmaceutical 's latest financial reports the company's current EPS (TTM) is $1.56. In 2022 the company made an earnings per share (EPS) of $2.30 an increase over its 2021 EPS that were of $0.87.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $1.56 | -32.03% |
2022 | $2.30 | 165.22% |
2021 | $0.87 | -55.82% |
2020 | $1.96 | 12.58% |
2019 | $1.74 | -72.57% |
2018 | $6.35 | 80.52% |
2017 | $3.52 | 11.11% |
2016 | $3.16 | 31.14% |
2015 | $2.41 | -13.47% |
2014 | $2.79 | -29.98% |
2013 | $3.98 | 4.54% |
2012 | $3.81 | -38.41% |
2011 | $6.18 | 51.48% |
2010 | $4.08 | 66.77% |
2009 | $2.45 |